| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0B013E3181EFD059 |
| P698 | PubMed publication ID | 20811321 |
| P50 | author | Gaetano Thiene | Q29840356 |
| Gino Gerosa | Q37838714 | ||
| Marialuisa Valente | Q47287943 | ||
| Elena Benazzi | Q57909886 | ||
| Sabino Iliceto | Q61165243 | ||
| P2093 | author name string | Francesca Poli | |
| Annalisa Angelini | |||
| Marny Fedrigo | |||
| Antonio Gambino | |||
| Francesco Tona | |||
| Giuseppe Feltrin | |||
| Giuseppe Toscano | |||
| Alida P Caforio | |||
| Gianluca Torregrossa | |||
| Annachiara Frigo | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 791-798 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? | |
| P478 | volume | 90 |
| Q39993576 | A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: the European experience |
| Q40108113 | Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection? |
| Q37994305 | Biomarkers of heart transplant rejection: the good, the bad, and the ugly! |
| Q48215946 | C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients. |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q38113123 | Diagnostic use of the endomyocardial biopsy: a consensus statement |
| Q54488322 | Does asymptomatic recurrent diffuse capillary C4d complement deposition impair cardiac allograft function? |
| Q37278134 | Increased complement activation in human type 1 diabetes pancreata |
| Q53637925 | Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP. |
| Q30544649 | Pros and cons for C4d as a biomarker |
| Q33407913 | Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy |
| Q37313051 | Report from a consensus conference on antibody-mediated rejection in heart transplantation |
| Q44940147 | The interplay of donor-specific antibodies, allograft C4d deposition, and antibody-mediated rejection |
| Q84969873 | The value of C4d deposit in post liver transplant liver biopsies |
| Q36488525 | Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation |
Search more.